about
Therapy Insight: AIDS-related malignancies—the influence of antiviral therapy on pathogenesis and managementSrc kinase becomes preferentially associated with the VEGFR, KDR/Flk-1, following VEGF stimulation of vascular endothelial cells.Next-Generation Sequencing in the Understanding of Kaposi's Sarcoma-Associated Herpesvirus (KSHV) BiologyEpstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developmentsEstimation of Cancer Burden Attributable to Infection in AsiaInterference with the Autophagic Process as a Viral Strategy to Escape from the Immune Control: Lesson from Gamma HerpesvirusesTargeting of prosurvival pathways as therapeutic approaches against primary effusion lymphomas: past, present, and FutureHerpesviruses: latency and reactivation - viral strategies and host responseEpstein-Barr virus: 40 years onDe novo infection with rhesus monkey rhadinovirus leads to the accumulation of multiple intranuclear capsid species during lytic replication but favors the release of genome-containing virions.Pathologic aspects of AIDS malignancies.3-D Microwell Array System for Culturing Virus Infected Tumor Cells.Introducing mediterranean journal of hematology and infectious diseases.Organization of capsid-associated tegument components in Kaposi's sarcoma-associated herpesvirusHigh seroprevalence of human herpesvirus type 8 in patients with hepatocellular carcinoma.The CD8 and CD4 T-cell response against Kaposi's sarcoma-associated herpesvirus is skewed towards early and late lytic antigens.KSHV manipulates Notch signaling by DLL4 and JAG1 to alter cell cycle genes in lymphatic endotheliaCD40 ligand (CD154) incorporated into HIV virions induces activation-induced cytidine deaminase (AID) expression in human B lymphocytes.Lymphocytes in cancer development: polarization towards pro-tumor immunityImmune Activation: Contribution to AIDS-Associated Non-Hodgkin LymphomaOncogene withdrawal engages the immune system to induce sustained cancer regression.An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman diseaseMolecular detection, quantification, and isolation of Streptococcus gallolyticus bacteria colonizing colorectal tumors: inflammation-driven potential of carcinogenesis via IL-1, COX-2, and IL-8.Cytotoxic and immune-sensitizing properties of nitric oxide-modified Saquinavir in iNOS-positive human melanoma cells.HIV and AIDS in relation to other pandemics. Among the viruses plaguing humans, HIV is a recent acquisition. Its outstanding success as an infection poses immense scientific challenges to human health and raises the question "What comes nest?".Kaposi's sarcoma-associated herpesvirus ORF18 and ORF30 are essential for late gene expression during lytic replication.Recreational drug use and risk of Kaposi's sarcoma in HIV- and HHV-8-coinfected homosexual men.CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivationAn essential role for the immune system in the mechanism of tumor regression following targeted oncogene inactivation.KSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies.AIDS and associated malignancies.Chemical compounds from anthropogenic environment and immune evasion mechanisms: potential interactionsInsights into pathogenic events of HIV-associated Kaposi sarcoma and immune reconstitution syndrome related Kaposi sarcoma.Perforin: structure, function, and role in human immunopathology.Activity of subcutaneous interleukin-12 in AIDS-related Kaposi sarcoma.Cytolytic T lymphocytes from HLA-B8+ donors frequently recognize the Hodgkin's lymphoma associated latent membrane protein 2 of Epstein Barr virus.Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells.Exposure to HIV-protease inhibitors selects for increased expression of P-glycoprotein (ABCB1) in Kaposi's sarcoma cells.Viral interleukin-6: role in Kaposi's sarcoma-associated herpesvirus: associated malignancies.Distinct memory CD4+ T-cell subsets mediate immune recognition of Epstein Barr virus nuclear antigen 1 in healthy virus carriers.
P2860
Q22251070-84B37EEE-ACDD-4DC9-A2CA-53E7738F6B67Q24796859-75F23DD3-0824-4E52-B7C4-8A0C18D0B306Q26752599-F2BBC9A3-BF73-4131-BF9C-84328D36FB08Q26775442-998B3961-36FB-4797-A936-932F19658118Q26781786-9DE82CAE-2323-45D1-8C7F-627872AC30FBQ28080898-317BC9D7-BD44-438D-BB48-FB81275ADB5EQ28081199-62CB7FCF-D83F-474C-86F0-2A93DD1FF3F9Q28662112-03EA02FE-28C8-47FB-BD03-092D55642E90Q29617969-A478C6C4-3D51-4157-97E1-901B6FB4ECE9Q30311978-6FFE79DD-95CD-4DAC-B761-130605FFB417Q30336144-8D454384-67B6-45DF-9C5D-FABA8D580339Q30367172-81BAEE6F-EE8E-41B7-90F6-D9E6FC3FC7FAQ30484888-8DEC682D-AC0F-4C4C-9EFF-9E708A98F721Q30603468-E715BB39-00A0-424A-8610-724529423073Q33416527-005B5E55-55E9-4CAB-83AD-A99FD612DF8CQ33470219-5A2F3341-B26C-4DF1-82AA-BB1793D7A532Q33509506-29AEDFDE-DFA1-4A61-8193-EA565E163FB0Q33631142-594B09CD-56EF-4538-B0ED-2EB3A9E7FA9DQ33712435-F766848F-E903-46F8-9410-B4DA88A3E3CFQ33887336-2210A9BF-73C4-41A7-B5E7-EA8C26FBF7AAQ33987633-53091920-233B-408F-B63B-2ACEE92C3087Q34157797-DA87EAFE-0FA5-4EBD-BF64-D2C00DE51AFDQ34158112-DA0945E6-508B-4FA3-B46D-090064261C9CQ34179539-2695856E-96C0-40CD-BF63-4E02C9C08B35Q34250687-F4E2C7FD-208F-4F80-B59A-198891CCE4E9Q34261905-17DDB4ED-91C5-4E41-AFD8-431104EBDED1Q34309880-AA41B43E-E387-4174-968B-8FDB660E888DQ34346803-B5546D9E-FCA6-48A0-9235-92A339017CA6Q34361976-EEC0464D-08D0-408D-BBDB-FE1053275358Q34417383-BE462EF5-8A55-441C-B141-648470AA2EE0Q34476365-A1219F4F-58D3-48D0-BE6F-C3ED94793060Q34477550-08695314-1B0C-4FB1-88EC-19CC201E1C53Q34587349-8CBE87B1-8BBC-447B-9D52-D41D59C6A661Q34620426-76946118-0F51-4E93-9522-9F14FD6E5ADCQ34667171-22300ECB-A966-4727-B7F7-A49EB916CE22Q34712758-FE0CE4F3-02E6-4E38-B841-8885DB89C341Q35128724-07D41E9D-9506-4154-8AF6-2CF4DFD5C9B4Q35208091-AD0BB5BC-14A0-45C1-AD94-57D899F646AAQ35550033-672D6C53-66DA-470F-BDBE-665740C938A3Q35616090-9EC58923-D617-401E-8E95-2D05A1C4A3EB
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Aids-related malignancies
@ast
Aids-related malignancies
@en
Aids-related malignancies
@en-gb
Aids-related malignancies
@nl
type
label
Aids-related malignancies
@ast
Aids-related malignancies
@en
Aids-related malignancies
@en-gb
Aids-related malignancies
@nl
altLabel
AIDS-related malignancies
@en
prefLabel
Aids-related malignancies
@ast
Aids-related malignancies
@en
Aids-related malignancies
@en-gb
Aids-related malignancies
@nl
P3181
P356
P1476
Aids-related malignancies
@en
P2093
Chris Boshoff
P2888
P304
P3181
P356
10.1038/NRC797
P407
P50
P577
2002-05-01T00:00:00Z
P6179
1009496899